Bloomberg Intelligence cover image

BI Weekend: Target, Home Depot, TJX Earnings

Bloomberg Intelligence

00:00

FDA Oversight and the Prescription Status of Finazopyridine

This chapter explores the FDA's absence of a monograph for finazopyridine, emphasizing the implications for its use and manufacturing. It raises alarms about the drug's prescription status amidst rising online sales and concludes with a nod to forthcoming discussions on diversity and equity in U.S. companies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app